Blog Post by Simbec Orion: selected as finalists for ‘Best Contract Research Organisation of the Year – Specialist Providers’ at the 14th Annual Scrip Awards.

Blog Post by Simbec Orion: We are delighted to have been selected as finalists for ‘Best Contract Research Organisation of the Year – Specialist Providers’ at the 14th Annual Scrip Awards. Our entry was selected based on demonstrating how our capabilities and strong operational delivery directly benefits small/mid -size drug developers meet their clinical and […]

Read More

Catalent Invests $7.3 Million at its Aprilia, Italy Facility Expands Softgel Encapsulation and Packaging Capabilities in Support of Consumer Health and Beauty Growth

Catalent Invests $7.3 Million at its Aprilia, Italy Facility Expands Softgel Encapsulation and Packaging Capabilities in Support of Consumer Health and Beauty Growth SOMERSET, N.J., October 4, 2018 – Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it had […]

Read More

Tioga Research is excited to announce that it has been named a Scrip Award finalist in the Best CRO – Specialist Providers category. The Scrip Award highlights the highest achievers of innovation in the biotechnology and pharmaceutical industries.

Tioga Research is excited to announce that it has been named a Scrip Award finalist in the Best CRO – Specialist Providers category. The Scrip Award highlights the highest achievers of innovation in the biotechnology and pharmaceutical industries. For more information, please click on the link below. https://pharmaintelligence.informa.com/events/awards/scrip-awards-2018/shortlist Tioga Research

Read More

Catalent Selected to Provide Oral Delivery Systems for GB Sciences’ Proprietary Parkinson’s Disease Therapies

Catalent Selected to Provide Oral Delivery Systems for GB Sciences’ Proprietary Parkinson’s Disease Therapies GB Sciences and Catalent tackle the first-ever formulations of APIs containing up to nine cannabinoids and terpenoids for the treatment of Parkinson’s disease SWINDON, U.K., and LAS VEGAS, September 26, 2018– GB Sciences, Inc. (OTCQB: GBLX) and Catalent Pharma Solutions, the […]

Read More

Aucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent for Vigabatrin Stick Pack Dosage Form

Aucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent for Vigabatrin Stick Pack Dosage Form Catalent Somerset, N.J. – September 4, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced a commercial supply agreement for Aucta Pharmaceuticals, Inc.’s (Aucta) vigabatrin. […]

Read More

Sherpa Clinical Packaging and De:terminence Announce Initiative to Help Rare Disease Patients Climb Mountains

Sherpa Clinical Packaging and De:terminence Announce Initiative to Help Rare Disease Patients Climb Mountains Sherpa Clinical Packaging Partnership will Raise Funds Dedicated to Purchasing Equipment and Training Programs for Rare Disease Patients   Sacramento and San Diego, CA, August 21, 2018 — Sherpa Clinical Packaging and De:terminence are pleased to announce a joint fundraiser to […]

Read More

Orthotopic PDX Models with Quantitative Pathology End Points Provide a New Standard in Translational Oncology Drug Development

Orthotopic PDX Models with Quantitative Pathology End Points Provide a New Standard in Translational Oncology Drug Development   Reveal Biosciences Orthotopic Patient-Derived Xenografts (PDX) Despite the rise of personalized approaches to the treatment of cancer, translating these therapies into a clinical setting still poses an exceptional challenge. This is highlighted in drug development where research […]

Read More